Free Trial

Celularity (CELUW) Competitors

Celularity logo
$0.04 +0.00 (+2.50%)
As of 02:08 PM Eastern

CELUW vs. ATNFW, LBPSW, AARD, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, and BCTXW

Should you be buying Celularity stock or one of its competitors? The main competitors of Celularity include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aardvark Therapeutics (AARD), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry.

Celularity vs.

Celularity (NASDAQ:CELUW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, community ranking, media sentiment, valuation, earnings, institutional ownership, analyst recommendations, risk and dividends.

Company Net Margins Return on Equity Return on Assets
CelularityN/A N/A N/A
180 Life Sciences N/A N/A N/A

In the previous week, 180 Life Sciences' average media sentiment score of 1.89 beat Celularity's score of 1.87 indicating that 180 Life Sciences is being referred to more favorably in the news media.

Company Overall Sentiment
Celularity Very Positive
180 Life Sciences Very Positive

Celularity and 180 Life Sciences both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
CelularityN/AN/A
180 Life SciencesN/AN/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Celularity$48.20MN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

Summary

Celularity and 180 Life Sciences tied by winning 1 of the 2 factors compared between the two stocks.

Remove Ads
Get Celularity News Delivered to You Automatically

Sign up to receive the latest news and ratings for CELUW and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CELUW vs. The Competition

MetricCelularityBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$115.04M$5.55B$7.86B
Dividend YieldN/A3.69%5.35%4.05%
P/E RatioN/A3.1523.4918.67
Price / SalesN/A4,117.09368.1387.32
Price / CashN/A13.0138.1634.64
Price / BookN/A35.646.634.09
Net IncomeN/A-$87.82M$3.20B$246.93M
7 Day PerformanceN/A-4.60%-6.38%-3.79%
1 Month PerformanceN/A58.27%-1.52%-6.75%
1 Year PerformanceN/A82.70%7.30%-1.88%

Celularity Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CELUW
Celularity
N/A$0.04
+2.5%
N/A-2.7%$0.00$48.20M0.00220Positive News
Gap Down
ATNFW
180 Life Sciences
N/A$0.01
flat
N/A-2.4%$0.00N/A0.007Positive News
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AARD
Aardvark Therapeutics
N/A$9.09
-1.6%
$30.50
+235.5%
N/A$0.00N/A0.0018Analyst Forecast
News Coverage
AEHAW
Aesther Healthcare Acquisition
N/A$0.02
+11.8%
N/A-92.1%$0.00N/A0.002Gap Up
AIMDW
Ainos
N/A$0.11
-34.3%
N/A+71.1%$0.00$20,729.000.0040Gap Down
ALVOW
Alvotech
N/A$2.36
-9.6%
N/A-54.2%$0.00$391.87M0.004Short Interest ↓
Positive News
Gap Down
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.03
flat
N/AN/A$0.00N/A0.0015
BFRIW
Biofrontera
N/A$0.09
flat
N/A-10.9%$0.00$35.36M0.0070Positive News
Gap Down
BTMDW
biote
N/A$0.07
flat
N/A-88.1%$0.00$197.19M0.00N/A
BCTXW
BriaCell Therapeutics
N/A$0.10
-7.1%
N/A-92.4%$0.00N/A0.008Positive News
Gap Down
Remove Ads

Related Companies and Tools


This page (NASDAQ:CELUW) was last updated on 4/1/2025 by MarketBeat.com Staff
From Our Partners